Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Niels Hellings

Showing results (1-10 of 130) with videos related to

Pageof 13
Sort By:
Critical Reviews in Immunology|August 29, 2017
Circulating Follicular Regulatory T Cells in Autoimmune Diseases and Their Waning in Multiple SclerosisTessa Dhaeze, Niels Hellings
Current Opinion in Investigational Drugs (London, England : 2000)|May 10, 2008
Tovaxin, radiation-attenuated, patient-specific T-cells for the therapeutic vaccination of multiple sclerosisNiels Hellings, Piet Stinissen
European Journal of Immunology|April 22, 2008
Activation of myelin reactive T cells in multiple sclerosis: a possible role for T cell degeneracy?Piet Stinissen, Niels Hellings
Critical Reviews in Immunology|August 27, 2013
Which immune cells matter? The immunopathogenesis of multiple sclerosisBieke Broux, Piet Stinissen, Niels Hellings
Autoimmunity Reviews|July 13, 2004
T-cell vaccination in multiple sclerosis: update on clinical application and mode of actionNiels Hellings, Jef Raus, Piet Stinissen
Annals of the New York Academy of Sciences|June 24, 2015
Immunomodulatory properties of the IL-6 cytokine family in multiple sclerosisKris Janssens, Helena Slaets, Niels Hellings
Frontiers in Immunology|June 14, 2019
Oncostatin M, an Underestimated Player in the Central Nervous SystemEvelien Houben, Niels Hellings, Bieke Broux
Immunologic Research|March 1, 2002
Insights into the immunopathogenesis of multiple sclerosisNiels Hellings, Jef Raus, Piet Stinissen
Expert Review of Clinical Immunology|May 19, 2010
T-cell-based immunotherapy in multiple sclerosis: induction of regulatory immune networks by T-cell vaccinationNiels Hellings, Jef Raus, Piet Stinissen
Frontiers in Immunology|July 29, 2022
When Helpers Go Above and Beyond: Development and Characterization of Cytotoxic CD4<sup>+</sup> T CellsCindy Hoeks, Gayel Duran, Niels Hellings, et al.
Pageof 13

Showing results (1-10 of 130) with videos related to

Sort By:
Pageof 13
Critical Reviews in Immunology|August 29, 2017
Circulating Follicular Regulatory T Cells in Autoimmune Diseases and Their Waning in Multiple SclerosisTessa Dhaeze, Niels Hellings
Current Opinion in Investigational Drugs (London, England : 2000)|May 10, 2008
Tovaxin, radiation-attenuated, patient-specific T-cells for the therapeutic vaccination of multiple sclerosisNiels Hellings, Piet Stinissen
European Journal of Immunology|April 22, 2008
Activation of myelin reactive T cells in multiple sclerosis: a possible role for T cell degeneracy?Piet Stinissen, Niels Hellings
Critical Reviews in Immunology|August 27, 2013
Which immune cells matter? The immunopathogenesis of multiple sclerosisBieke Broux, Piet Stinissen, Niels Hellings
Autoimmunity Reviews|July 13, 2004
T-cell vaccination in multiple sclerosis: update on clinical application and mode of actionNiels Hellings, Jef Raus, Piet Stinissen
Annals of the New York Academy of Sciences|June 24, 2015
Immunomodulatory properties of the IL-6 cytokine family in multiple sclerosisKris Janssens, Helena Slaets, Niels Hellings
Frontiers in Immunology|June 14, 2019
Oncostatin M, an Underestimated Player in the Central Nervous SystemEvelien Houben, Niels Hellings, Bieke Broux
Immunologic Research|March 1, 2002
Insights into the immunopathogenesis of multiple sclerosisNiels Hellings, Jef Raus, Piet Stinissen
Expert Review of Clinical Immunology|May 19, 2010
T-cell-based immunotherapy in multiple sclerosis: induction of regulatory immune networks by T-cell vaccinationNiels Hellings, Jef Raus, Piet Stinissen
Frontiers in Immunology|July 29, 2022
When Helpers Go Above and Beyond: Development and Characterization of Cytotoxic CD4<sup>+</sup> T CellsCindy Hoeks, Gayel Duran, Niels Hellings, et al.
Pageof 13